The Kd of the EGCG binding to HIF-1α is 3.47 μM [34], which is compatible to the highest plasma peak EGCG level (i.e. 7-10 μM) in the experimental animals administered with diet containing high dose of EGCG [2,35], suggesting the possibility that miR-210 may play a role inhibiting lung cancer in vivo. The gene discussed is HIF1A; the disease is lung carcinoma.